China NMPA Product Recall - Distal Access Catheter

Stryker Neurovascular, operating through its affiliate Stryker (Beijing) Medical Devices Co., Ltd., has initiated a voluntary Class III recall of its Distal Access Catheters. This action, publicly announced by the National Medical Products Administration (NMPA) on April 17, 2024, is in response to manufacturing deficiencies resulting in excessive endotoxin levels within the affected medical devices. Specifically, products bearing serial number 20153033928 are among those impacted, with comprehensive details regarding specific models, specifications, and batch numbers documented in the "Medical Device Recall Event Report Form" referenced in the NMPA's announcement. This proactive recall demonstrates Stryker's dedication to upholding patient safety and complying with the stringent regulatory standards established by the NMPA. Although a Class III recall typically signifies that the defect is unlikely to cause serious adverse health consequences, Stryker is taking decisive steps to rectify the quality issue. The company is mandated to identify and remove all affected products from distribution to safeguard the safety and effectiveness of its medical devices, underscoring the critical importance of rigorous quality control and regulatory oversight in the medical device sector.